Activin and Inhibin

CPI-455 is a specific, pan- KDM5 inhibitor with an IC 50 of 10 nM for KDM5A. CPI-455 mediates KDM5 inhibition, elevates global levels of H3K4me3, and decreases the number of drug-tolerant persister cancer cells in multiple cancer cell line models

CPI-455 is a specific, pan- KDM5 inhibitor with an IC 50 of 10 nM for KDM5A. CPI-455 mediates KDM5 inhibition, elevates global levels of H3K4me3, and decreases the number of drug-tolerant persister cancer cells in multiple cancer cell line models

CPI-455 is a specific, pan- KDM5 inhibitor with an IC 50 of 10 nM for KDM5A. CPI-455 mediates KDM5 inhibition, elevates global levels of H3K4me3, and decreases the number of drug-tolerant persister cancer cells in multiple cancer cell line models

CPT-157633, a difluoro-phosphonomethyl phenylalanine derivative, and is a PTP1B inhibitor. CPT-157633 prevents binge drinking-induced glucose intolerance.In VivoCPT-157633 (0.2 µg/day: intracerebroventricular infusion) alleviates the hypothalamic

CPT-157633, a difluoro-phosphonomethyl phenylalanine derivative, and is a PTP1B inhibitor. CPT-157633 prevents binge drinking-induced glucose intolerance.In VivoCPT-157633 (0.2 µg/day: intracerebroventricular infusion) alleviates the hypothalamic

CR-1-31-B is a synthetic rocaglate and a potent eIF4A inhibitor. CR-1-31-B exhibits powerful inhibitory effects over eIF4A by perturbing the interaction between eIF4A and RNA, sequentially impeding initiation during protein synthesis. CR-1-31-B

CR-1-31-B is a synthetic rocaglate and a potent eIF4A inhibitor. CR-1-31-B exhibits powerful inhibitory effects over eIF4A by perturbing the interaction between eIF4A and RNA, sequentially impeding initiation during protein synthesis. CR-1-31-B

CR-1-31-B is a synthetic rocaglate and a potent eIF4A inhibitor. CR-1-31-B exhibits powerful inhibitory effects over eIF4A by perturbing the interaction between eIF4A and RNA, sequentially impeding initiation during protein synthesis. CR-1-31-B

CRA-2059 is a highly specific and selective tryptase inhibitor, with a K i of 620 pM for recombinant human tryptase-β (rHTβ).Appearance:SolidIn Vitro:Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell

CRA-2059 is a highly specific and selective tryptase inhibitor, with a K i of 620 pM for recombinant human tryptase-β (rHTβ).Appearance:SolidIn Vitro:Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell

CRA-2059 is a highly specific and selective tryptase inhibitor, with a K i of 620 pM for recombinant human tryptase-β (rHTβ).Appearance:SolidIn Vitro:Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell

Creatinol Phosphate.